AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
79.01%
Total 13F principal
$312,441,940
Principal change
-$4,618,000
Total reported market value
$249,371,000
Number of holders
21
Value change
-$2,707,429
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q2 2020

As of 30 Jun 2020, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $312,441,940 in principal (par value) of the bond. The largest 10 bondholders included BlackRock Inc., UBS OCONNOR LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ANGELO GORDON & CO., L.P., WOLVERINE ASSET MANAGEMENT LLC, Birch Grove Capital LP, Whitebox Advisors LLC, CITADEL ADVISORS LLC, AMERIPRISE FINANCIAL INC, and GOLDMAN SACHS GROUP INC. This page lists 21 institutional bondholders reporting positions for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.